Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study-Reference-Cited by-同舟云学术

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study

Published:2023-01 Issue:1 Volume:41 Page:251-262
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Willame C,Dodd C,Durán CE,Elbers RJHJ,Gini R,Bartolini C,Paoletti O,Wang L,Ehrenstein V,Kahlert J,Haug U,Schink T,Diez-Domingo J,Mira-Iglesias A,Carreras JJ,Vergara-Hernández C,Giaquinto C,Barbieri E,Stona L,Huerta C,Martín-Pérez M,García-Poza P,de Burgos A,Martínez-González M,Bryant V,Villalobos F,Pallejà-Millán M,Aragón M,Carreras JJ,Souverein P,Thurin NH,Weibel D,Klungel OH,Sturkenboom MCJM

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies;Ahmed;Viruses,2020

2. An interactive website tracking COVID-19 vaccine development;Shrotri;Lancet Glob Heal,2021

3. A global database of COVID-19 vaccinations;Mathieu;Nat Hum Behav,2021

4. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination;Scully;N Engl J Med,2021

5. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination;Schultz;N Engl J Med,2021

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between COVID-19 Vaccines and Menstrual Disorders: Retrospective Cohort Study of Women Aged 12–55 Years Old in Catalonia, Spain;International Journal of Environmental Research and Public Health;2024-08-18

2. Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group”;Frontiers in Drug Safety and Regulation;2024-08-12

3. Background incidence rates of health outcomes of interest for COVID-19 vaccine safety monitoring in a US population: a claims database analysis;BMJ Open;2024-07

4. Current Approaches in Postapproval Vaccine Safety Studies Using Real-World Data: A Systematic Review of Published Literature;Clinical Therapeutics;2024-07

5. Variation in incidence rates of outcomes relevant to vaccine safety monitoring in a US commercially insured population by case identification algorithm;Vaccine;2024-07